netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
    • RESEARCH REPORTS
  • 2022 AGM NOTICE
  • CONTACT US
netscientific
netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
    • RESEARCH REPORTS
  • 2022 AGM NOTICE
  • CONTACT US

Director/PDMR Shareholding

Jun 27, 2022
-
News, RNS Announcements

 

NetScientific plc

Director/PDMR Shareholding

NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation group, announced on 22 June 2022, that it had closed its Placing of 2,238,807 Placing Shares at a Placing Price of 67 pence per Placing Share.

 

Dr Ilian Iliev and Mr John Clarkson (each a Director of the Company) and Mr Stephen Crowe (CFO) each participated in the Placing and as persons discharging managerial responsibilities in respect of the Company details of their participation are set out below.

 

Unless otherwise defined, terms used in this announcement shall have the same meanings as those defined in the Company’s announcement dated 22 June 2022.

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Dr Ilian Petkov Iliev
2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director
b)

 

Initial notification /Amendment

 

 

Initial Notification
3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

NetScientific plc
b)

 

LEI

 

 

213800N5WD46G1Y7I458
4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.05 each

 

 

 

 

GB00BN4R5Q82

b)

 

Nature of the transaction

 

 

Participation in placement
c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)
£0.67 21,641 Ordinary Shares

 

 

d)

 

Aggregated information

 

 

– Aggregated volume

 

 

– Price

 

 

 

 

 

N/A

e)

 

Date of the transaction

 

 

27 June 2022
f)

 

Place of the transaction

 

 

UK AIM

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

John Eric Clarkson
2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director
b)

 

Initial notification /Amendment

 

 

Initial Notification
3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

NetScientific plc
b)

 

LEI

 

 

213800N5WD46G1Y7I458
4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.05 each

 

 

 

 

GB00BN4R5Q82

b)

 

Nature of the transaction

 

 

Participation in placement
c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)
£0.67 59,701 Ordinary Shares

 

 

d)

 

Aggregated information

 

 

– Aggregated volume

 

 

– Price

 

 

 

 

 

N/A

e)

 

Date of the transaction

 

 

27 June 2022
f)

 

Place of the transaction

 

 

UK AIM

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen Daniel Crowe
2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer
b)

 

Initial notification /Amendment

 

 

Initial Notification
3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

NetScientific plc
b)

 

LEI

 

 

213800N5WD46G1Y7I458
4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.05 each

 

 

 

 

GB00BN4R5Q82

b)

 

Nature of the transaction

 

 

Participation in placement
c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)
£0.67 22,388 Ordinary Shares

 

 

d)

 

Aggregated information

 

 

– Aggregated volume

 

 

– Price

 

 

 

 

 

N/A

e)

 

Date of the transaction

 

 

27 June 2022
f)

 

Place of the transaction

 

 

UK AIM

 

 

 

About NetScientific

NetScientific plc (AIM: NSCI) is a holding company, that invests in, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies, which offer significant growth potential in the UK, Europe and USA, as well as globally.

 

Since the adoption of the New Strategy in 2020, the Group has nearly trebled its portfolio from 8 to 22 companies, either through subsidiary, direct balance sheet investment or capital under advisory.

 

NetScientific delivers shareholder returns through a proactive and hands-on management approach to their portfolio companies; identifying, investing in, and helping to build game-changing companies. The Group targets value inflection points and the release of value through partial or full exits from trade sales, public listings, or equity sales. The Company has a strong transatlantic and growing international presence, providing attractive expansion prospects.

 

NSCI can deploy a capital-light investment structure; utilising the power of the PLC Brand, and the NetScientific balance sheet to anchor future investments and achieve a multiplier effect by attracting third party investment for the portfolio companies.

 

NetScientific is headquartered in London, United Kingdom, and was admitted to trading on AIM, a market operated by the London Stock Exchange, in 2013 (website: www.netscientific.net).

Share on FacebookShare on TwitterShare on Linkedin
← PREVIOUS POST
PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update
NEXT POST →
TR-1: Standard form for notification of major holdings

 

NetScientific plc

Level 39,
One Canada Square,
London, E14 5AB

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

  • RNS & RNS Reach
  • Financial Results
  • Financial Calendar
  • Corporate Governance
  • News
  • Historic Material
Copyright
Terms of Use
Director/PDMR Shareholding - NetScientific
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT